Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

NCT01077986 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: Capecitabine
DRUG: Cetuximab
DRUG: Everolimus

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)